Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin and Saffron in Women with Diabetes
NCT06413238Phase 2Not yet recruiting
- Start
- Jun 2024
- Primary completion
- Dec 2024
01
Overview
Phase 2, randomised, triple-blind trial (4 arms). Primary endpoints: Fasting Blood Sugar, Hemoglobin A1c and 4 more. Planned start Jun 2024; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06413238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06413238.